Hypofractionated Radiotherapy plus Cetuximab in Locally Advanced Head and Neck Cancer

被引:7
|
作者
Teoh, D. C. [1 ]
Rodger, S. [2 ]
Say, J. [2 ]
Hartley, A. [1 ]
机构
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Fac Med, Birmingham, W Midlands, England
关键词
D O I
10.1016/j.clon.2008.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:717 / 717
页数:1
相关论文
共 50 条
  • [31] INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT RADIOTHERAPY PLUS CETUXIMAB IN PATIENTS WITH UNRESECTABLE ADVANCED HEAD AND NECK CANCER
    Calvo, M.
    Vazquez, S.
    Lozano, A.
    Teule, A.
    Manos, M.
    Nogues, J.
    Perez, X.
    Vilajosana, E.
    Elez, E.
    Mesia, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 221 - 221
  • [32] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [33] Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: A retrospective study
    Imai, Chiaki
    Saeki, Hiromi
    Yamamoto, Kohei
    Ichikawa, Ayano
    Arai, Makoto
    Tawada, Akinobu
    Suzuki, Takaaki
    Takiguchi, Yuichi
    Hanazawa, Toyoyuki
    Ishii, Itsuko
    ONCOLOGY LETTERS, 2022, 23 (05)
  • [34] Locally advanced head and neck cancer: chemoradiotherapy or acceleration of radiotherapy?
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2012, 99 (10) : 901 - 902
  • [35] Hypothyroidism after Radiotherapy of Locally Advanced Head and Neck Cancer
    Lee, Jeong Eun
    Kim, Jae-Chul
    Yea, Ji Woon
    Park, In Kyu
    RADIATION ONCOLOGY JOURNAL, 2010, 28 (02): : 64 - 70
  • [36] POSTOPERATIVE RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER
    FRANCHIN, G
    DEPAOLI, A
    GOBITTI, C
    BOZ, G
    MINATEL, E
    RONCADIN, M
    ARCICASA, M
    BORTOLUS, R
    INNOCENTE, R
    TROVO, GM
    GRIGOLETTO, E
    TUMORI, 1989, 75 (01) : 47 - 52
  • [37] Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
    Walsh, Lorraine
    Gillham, Charles
    Dunne, Mary
    Fraser, Ian
    Hollywood, Donal
    Armstrong, John
    Thirion, Pierre
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 38 - 41
  • [38] Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer
    Strom, Tobin J.
    Trotti, Andy M.
    Kish, Julie
    Russell, Jeffery S.
    Rao, Nikhil G.
    McCaffrey, Judith
    Padhya, Tapan A.
    Otto, Kristen J.
    Caudell, Jimmy J.
    ORAL ONCOLOGY, 2015, 51 (07) : 704 - 708
  • [39] Cost-effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain
    Brosa, M.
    Robinson, P.
    Brown, B.
    VALUE IN HEALTH, 2006, 9 (06) : A281 - A281
  • [40] Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients
    Kurokawa, Marie
    Watanabe Nemoto, Miho
    Harada, Rintaro
    Kobayashi, Hiroki
    Horikoshi, Takuro
    Kanazawa, Aki
    Togasaki, Gentaro
    Abe, Yukinao
    Chazono, Hideaki
    Hanazawa, Toyoyuki
    Okamoto, Yoshitaka
    Uno, Takashi
    JOURNAL OF RADIATION RESEARCH, 2015, 56 (05) : 849 - 855